Injectable Anti-diabetic Drugs Market Expected to Reach @marketSize @valueUnit by 2033
The injectable anti-diabetic drugs market, projected at $38.79B in 2025, is booming, driven by rising diabetes prevalence and advancements in insulin and GLP-1 agonists. Explore market trends, leading players (Novo Nordisk, Sanofi, Eli Lilly), and regional insights for 2025-2033.